Whilst these medications have a well-established safety profile, patients occasionally report concerns about swollen lymph nodes during treatment
Los estudios STEP (Semaglutide Treatment Effect in People with obesity) demostraron que los participantes perdieron en promedio 12.4% de su peso corporal en 68 semanas con semaglutida 2.4 mg, comparado con 2.4% en el grupo placebo
Gao R, Tao Y, Zhou C, et al
The advantage is smaller injection volumes
When To Consult a Doctor While occasional constipation is common and typically not a cause for concern, persistent constipation that significantly impacts your quality of life should be addressed by your doctor, particularly if you've tried over-the-counter remedies like fiber supplements and osmotic laxatives without success
Several factors related to weight loss and dietary changes during Saxenda treatment may contribute to alterations in urine odour, even though the medication itself does not directly cause this effect